ストックスクリーナーアプリを入手
151.59
1.01%
-1.145
前日終値:
$152.74
開ける：
$152.34
24時間の取引高:
3.75M
Relative Volume:
0.52
時価総額：
$188.04B
収益：
$29.42B
当期純損益:
$8.51B
株価収益率:
22.36
EPS:
6.7801
ネットキャッシュフロー:
$10.02B
1週間 パフォーマンス:
-0.40%
1か月 パフォーマンス:
+21.05%
6か月 パフォーマンス:
+28.16%
1年 パフォーマンス:
+40.46%
1日の値動き範囲:
$150.33
$152.81
1週間の範囲:
$150.33
$156.95
52週間の値動き範囲:
$93.37
$157.29
Gilead Sciences Inc Stock (GILD) Company Profile
Compare GILD vs LLY, JNJ, ABBV, AZN, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
151.56 | 189.50B | 29.42B | 8.51B | 10.02B | 6.7801 |
|
LLY
Lilly Eli Co
|
1,020.72 | 962.75B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
245.94 | 590.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
224.16 | 404.24B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
207.15 | 323.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
163.45 | 315.57B | 54.72B | 14.02B | 15.32B | 7.1855 |
Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-11 | 繰り返されました | Needham | Buy |
| 2026-01-07 | 再開されました | UBS | Buy |
| 2025-11-24 | 再開されました | Truist | Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-08-19 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | アップグレード | Truist | Hold → Buy |
| 2025-07-25 | アップグレード | Needham | Hold → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 繰り返されました | Oppenheimer | Outperform |
| 2025-02-18 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-13 | アップグレード | DZ Bank | Hold → Buy |
| 2025-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-11-08 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 繰り返されました | Maxim Group | Buy |
| 2024-04-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-02-22 | ダウングレード | Truist | Buy → Hold |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Reduce |
| 2023-07-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-16 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 再開されました | Piper Sandler | Overweight |
| 2023-01-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 再開されました | BofA Securities | Neutral |
| 2022-12-09 | ダウングレード | DZ Bank | Buy → Hold |
| 2022-10-31 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2022-10-28 | 繰り返されました | Cowen | Outperform |
| 2022-10-28 | 繰り返されました | JP Morgan | Overweight |
| 2022-10-28 | 繰り返されました | Jefferies | Buy |
| 2022-10-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-10-28 | アップグレード | Truist | Hold → Buy |
| 2022-10-28 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-10-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-28 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-02 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-02 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-02-02 | 繰り返されました | Truist | Hold |
| 2022-02-02 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Argus | Hold → Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 再開されました | Piper Sandler | Neutral |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-07-30 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2021-07-30 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2021-04-01 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-01-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-09-30 | 再開されました | Jefferies | Buy |
| 2020-09-15 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-31 | 繰り返されました | Credit Suisse | Neutral |
| 2020-07-31 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 繰り返されました | Piper Sandler | Overweight |
| 2020-07-31 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2020-07-31 | 繰り返されました | SunTrust | Hold |
| 2020-07-31 | 繰り返されました | Wells Fargo | Equal Weight |
| 2020-07-20 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | アップグレード | SunTrust | Sell → Hold |
| 2020-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-05-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | ダウングレード | SunTrust | Hold → Sell |
| 2020-04-27 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
すべてを表示
Gilead Sciences Inc (GILD) 最新ニュース
What Do Analysts Have to Say About Gilead Sciences (GILD) Post Earnings? - Insider Monkey
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now? - Yahoo Finance
Gilead Sciences, Inc. $GILD Shares Purchased by NewEdge Wealth LLC - MarketBeat
Hodges Capital Management Inc. Takes Position in Gilead Sciences, Inc. $GILD - MarketBeat
Insider Sell: Andrew Dickinson Sells 3,000 Shares of Gilead Scie - GuruFocus
Insider Selling: Gilead Sciences (NASDAQ:GILD) CFO Sells 3,000 Shares of Stock - MarketBeat
Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push - BioWorld MedTech
Gilead Sciences to Present New HIV Treatment and Prevention Data at CROI 2026 - National Today
UBS raises Gilead Sciences stock price target on HIV pipeline data - Investing.com
Mizuho Securities Lifts Gilead Sciences Price Target to $170 From $140, Maintains Outperform Rating - marketscreener.com
[Press release] Gilead to present new HIV treatment and prevention data at CROI 2026, with a focus on expanding options - European AIDS Treatment Group
Gilead Sciences, China's Qinhao Pharmaceutical Sign Global Deal for Tumor Therapy Candidate - marketscreener.com
Gilead Sciences (GILD) Secures Rights to Genhouse Bio's Cancer T - GuruFocus
Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Opti - PharmiWeb.com
Gilead’s HIV Advances And Yescarta Label Shift Refocus Investment Thesis - Yahoo Finance
Rothschild & Co Redburn Adjusts Gilead Sciences PT to $170 From $159, Maintains Buy Rating - marketscreener.com
Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options - Business Wire
5 Insightful Analyst Questions From Gilead Sciences's Q4 Earnings Call - Finviz
NEOS Investment Management LLC Has $64.06 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
M&G PLC Has $10.82 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Skandinaviska Enskilda Banken AB publ - MarketBeat
Fifth Third Bancorp Has $43.69 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Investors heavily search Gilead Sciences, Inc. (GILD): Here is what you need to know - MSN
Gilead Sciences, Inc. (GILD): Investor Outlook on Robust Growth and Strategic Collaborations - DirectorsTalk Interviews
Zions Bancorporation National Association UT Has $4.46 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Vanguard Group Inc. Has $13.21 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Todd Asset Management LLC Sells 22,499 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead strikes $1.5 billion cancer pact with Genhouse Bio - The Pharma Letter
Gilead Sciences, Inc. $GILD Shares Purchased by Public Sector Pension Investment Board - MarketBeat
Analyst recommendations: Eagle Materials, Coinbase Global, Gilead Sciences, Royal Gold… - marketscreener.com
5 Insightful Analyst Questions From Gilead Sciences’s Q4 Earnings Call - The Globe and Mail
Shell Asset Management Co. Sells 54,965 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
State of New Jersey Common Pension Fund D Buys 16,160 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Assetmark Inc. Acquires 28,701 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Aberdeen Group plc Sells 160,874 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
The Centrifuge Sessions: How Gilead Sciences Is Impacting Autoimmune Disease - CSRwire
PatientView Ranks Gilead “Best” at ESG - CSRwire
Gilead Sciences (GILD) Tops Earnings but Shares Fall on Guidance - GuruFocus
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Leerink Partners Analyst Says - MarketBeat
Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.82 - Yahoo Finance
BTC Capital Management Inc. Buys 64,668 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Florida Financial Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Is Gilead Sciences Inc. stock a good pick for beginners2025 Support & Resistance & Precise Swing Trade Alerts - mfd.ru
Cookson Peirce & Co. Inc. Increases Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know - Yahoo! Finance Canada
Can Gilead's HIV Portfolio Sustain Its Growth Trend in 2026? - The Globe and Mail
BofA Raises PT on Gilead Sciences (GILD) to $162 From $154Here's Why - Bitget
BofA Raises PT on Gilead Sciences (GILD) to $162 From $154 – Here’s Why - Insider Monkey
Focus on These 5 Stocks That Recently Hiked Dividends - TradingView
Gilead Sciences Inc (NASDAQ:GILD) Offers a Sustainable Dividend Backed by Strong Fundamentals - ChartMill
Longbow Finance SA Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Inc (GILD) 財務データ
収益
当期純利益
現金流量
EPS
Gilead Sciences Inc (GILD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mercier Johanna | Chief Comm & Corp Aff Officer |
Feb 17 '26 |
Sale |
154.44 |
28,000 |
4,324,228 |
120,288 |
| Dickinson Andrew D | Chief Financial Officer |
Feb 17 '26 |
Sale |
154.43 |
3,000 |
463,290 |
167,779 |
0.38%
大文字化:
|
ボリューム (24 時間):